Follow us for updates
© 2022 reportr.world
Read the Story →

Omicron Symptoms Last 3 Days Shorter for Boosted Persons: Study

Compared to Delta.
by Agence France Presse
Apr 8, 2022
Photo/s: Jerome Ascaño
Shares

People who are vaccinated and have had a booster shot against COVID-19 recover from symptoms from the Omicron variant more than three days earlier than those with the Delta variant, a study said Friday.

The study also found that people with Omicron are significantly less likely to lose their sense of smell, and confirmed previous research that it is less severe.

To find out the differences in how Omicron and Delta make sufferers sick, researchers used a free smartphone app called ZOE on which more than 63,000 vaccinated people in Britain aged 16-99 self-reported their COVID symptoms between June 2021 and January 2022. 

For those with two vaccine doses plus a booster, symptoms from Omicron lasted 4.4 days, compared to 7.7 for Delta -- a difference of 3.3 days. 

MORE ON COVID-19:

COVID Increases Risk of Blood Clots for Up to Six Months: Study

Worst-Case Scenario for COVID in 2022 is a Virulent Variant: WHO

Continue reading below ↓

People who had two doses but no booster shot saw Omicron symptoms clear up in 8.3 days, compared to 9.6 days for Delta, according to the study published in the Lancet medical journal.

The swifter recovery suggests "that the period of infectiousness might be shorter, which would in turn impact workplace health policies and public health guidance," the researchers said.

The study, which will be presented at the European Congress of Clinical Microbiology and Infectious Diseases in Lisbon later this month, also found that only 17% of those with Omicron lost their sense of smell, compared to 53% for Delta.

However, people with Omicron had a 55% increased risk of getting a sore throat and were 24% more likely to develop a hoarse voice.

The study also found that Omicron patients were 25% less likely to be admitted to the hospital.

Study author Cristina Menni of King's College London said it was the first peer-reviewed paper with a large number of participants that looked at the different symptoms of the two variants.

Continue reading below ↓
Recommended Videos

While the study covered a period before the Omicron BA.2 variant swept the world, "recent data from the app show no change in symptoms in BA.2 compared to BA.1," she told AFP.

READ:

Why COVID Survivors Appear More Likely to Develop Diabetes

Reportr is now on Quento. Download the app or visit the Quento website for more articles and videos from Reportr and your favorite websites.

Latest Headlines
Read Next
Recent News
Ukay-ukay is actually prohibited under the law, the senator said.
Shedding light on the origins of life.
With the reopening of several local destinations, this app has never been more timely.
As proposed by Sen. Robin Padilla.
For 'strong immune response' against omicron, original virus.
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.